Growth Factor Cocktail Including Fibroblast Growth Factor 9 in the Treatment of Androgenetic Alopecia in Men and Women: A Randomized Controlled Trial

    Leonardo de Medeiros Quirino, Giovana Vilela Rocha
    From the encyclopedia
    Microneedling →

    technique to create small wounds in skin to activate collagen production and hair growth

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Image
    Studysummary In this randomized controlled trial, researchers found that Cellcurin therapy significantly increased hair density, terminal hair, and vellus hair counts in men and women with androgenetic alopecia, compared to minoxidil control, over 12 weeks.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    A study involving 16 men and women evaluated the effectiveness of Cellcurin, a growth factor cocktail, in treating Androgenetic Alopecia (AGA). The treatment was administered via microneedling, and compared to a control group of 4 patients who received microneedling with 0.5% minoxidil. After 12 weeks, women in the treatment group showed an 86.96% increase in hair per cm2 in the frontal area and 59.52% in the vertex area. Men in the treatment group showed a 46.72% increase in the frontal area and 50.80% in the vertex region. Both genders also saw a significant increase in terminal hair diameters per cm2. The study concluded that Cellcurin therapy via microneedling effectively treats AGA by increasing hair density and thickness. The study also suggested that gender and racial differences may affect treatment effectiveness.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results